Search results for: 'biologics particul analyst'
- Did you mean
- biologics particip analyst
- biologics particul analysi
- Related search terms
- biologics contract development amp manufacturing market forecast to 2022
- biologics market size 2024
- Biologics Contract Development and Manufacturing
- biologics market size 2026
- biologics contract development ad manufacturing organizations
-
20 Nov 2017  |  North America  |  Market Research
Global Biologics Market—Companies-to-Action
Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development
This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...
$3,000.00
Special Price $2,250.00 save 25 %
-
19 Sep 2018  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Jul 2020  |  North America  |  Market Research
Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024
Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies
With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Feb 2022  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organization Profiles and Growth Opportunities
The Contract Research, Development, and Manufacturing Organization Business Model to Drive Future Growth Potential
Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...
$2,450.00
Special Price $1,837.50 save 25 %
-
17 Jun 2021  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities
Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential
This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...
$4,950.00
Special Price $3,712.50 save 25 %
-
02 May 2011  |  North America  |  Market Research
U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments
This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Market challenges, drivers, and restraints are identified and assessed. Strategic recommendations are presented ...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Jun 2022  |  North America  |  Market Research
Growth Opportunities in Sterile Injectable Outsourcing
Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing
Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...
$2,450.00
Special Price $1,837.50 save 25 %
-
31 Aug 2006  |  North America  |  Market Research
World Chemical and Biological Agent Detector Markets
The world chemical and biological agent detection market report covers all topics related to this industry. The size of the U.S. market, both military and civilian, is discussed in detail. The world market, which, includes European, Asian, and Middle Eastern markets are also covered. While analyzing the market, the total market size as well as mark...
$4,950.00
Special Price $3,712.50 save 25 %
-
06 Nov 2006  |  North America  |  Market Research
U.S. Chemical Biological and Nuclear Detection Markets
This research service provides insights about the U.S. chemical biological and nuclear detection market.
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Feb 2017  |  North America  |  Market Research
Trends, Opportunities, and Future of the Global Pharma Extractables and Leachables Testing Market
Growing Prominence of Single Use Technologies and Biologics Market Driving Growth
This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is ...
$1,500.00
Special Price $1,125.00 save 25 %